The Value of the ACHC/IgNS Distinction in Immunoglobulin Therapy

Originally published by our sister publication Specialty Pharmacy ContinuumAmy E. Clarke, DNP, RN, IgCN®Chief Clinical OfficerImmunoglobulin National SocietyCalabasas, CaliforniaLuba Sobolevsky, PharmD, IgCP®President and CEOImmunoglobulin National SocietyCalabasas, CaliforniaCaroline Girardeau, PharmD, MBA, PMP, BCPSPharmacy Program DirectorAccreditation Commission for Health CareCary, North CarolinaImmunoglobulin (Ig) therapy stands among the most clinically nuanced and operationally c